Brode v. Xeris Pharmaceuticals, Inc.

District Court, N.D. Illinois·Decided November 2, 2023·No. 1:22-cv-02903·Unknown

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

ALEXIS BRODE,

Plaintiff, No. 22 CV 2903 v. Judge Manish S. Shah XERIS PHARMACEUTICALS, INC.,

Defendant.

ORDER Defendant’s motion to dismiss, [24], is granted. The amended complaint is dismissed with prejudice. Enter judgment and terminate civil case. STATEMENT Alexis Brode sued her former employer, Xeris Pharmaceuticals, alleging that it violated her rights under the American with Disabilities Act when it instituted a COVID-19 vaccine requirement for its employees. [1].1 Xeris moved to dismiss Brode’s first complaint, [8], and I granted the motion without prejudice. [21]. Brode filed an amended complaint, [22], and Xeris once again moves to dismiss for failure to state a claim. [24]. Because Brode fails to state a plausible claim for relief under the ADA, Xeris’s second motion to dismiss, [24], is granted and this case is closed. A complaint must contain factual allegations that state the required elements of the plaintiff’s claim in a way that “raise[s] a right to relief above the speculative level” to meet federal pleading requirements. Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007). The court takes all well-pleaded factual allegations in the complaint as true and draws reasonable inferences in the plaintiff’s favor. Bronson v. Ann & Robert H. Lurie Child. Hosp. of Chicago, 69 F.4th 437, 448 (7th Cir. 2023). The court does not accept conclusory allegations that just re-state the elements of a claim. Id. The court then considers those well-pleaded allegations and determines whether the

1 Bracketed numbers refer to entries on the district court docket and page numbers refer to the CM/ECF header placed at the top of filings. Written instruments attached to the complaint are part of the complaint, see Fed. R. Civ. P. 10(c), so I consider Brode’s affidavit, filed as docket entry [23]. plaintiff’s claim is plausible, which requires “more than a sheer possibility that a defendant has acted unlawfully.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). Brode was a top-performing sales representative with Strongbridge Biopharma until it merged with Xeris Pharmaceuticals in October 2021. [22] at 10, ¶ 10. She was notified that Xeris required its employees to be vaccinated against COVID-19. Id. ¶¶ 11–12. In mid-October, Brode spoke on the phone with Xeris’s Chief Commercial Officer; she said that she wanted to do research on the risks and benefits of the vaccine and that getting the vaccine was a personal decision. Id. ¶ 15. The Chief Commercial Officer replied that while he respected her position, Xeris might not be the right place for her. Id. Brode contacted Xeris’s HR department and asked about exemptions; she was told to submit a request for a religious exemption. [22] at 10–11, ¶¶ 16–17. Brode submitted her request for an exemption from the COVID-19 vaccine requirement in early November. [22] at 11, ¶ 18. Xeris approved her request and granted the accommodation of being placed on unpaid personal leave until Brode became vaccinated or the company ended its vaccination requirement. Id. ¶ 19. Brode protested the accommodation, stating it seemed like Xeris was firing her and she was not leaving the company voluntarily. Id. ¶ 20. Brode was placed on unpaid leave at the end of November 2021. Id. ¶ 22. In March 2022, Brode sent HR an email titled “Notice of Discrimination and Harassment Based upon Disability” in which she wrote that Xeris was perceiving her as disabled and violating her rights under the ADA by requiring a COVID-19 vaccine. [22] at 11–12, ¶¶ 23–28. Brode then filed a charge of discrimination on the basis of disability and retaliation with the EEOC. [22] at 12, ¶ 29. Brode arranged a conversation with Xeris’s HR and Chief Legal Officer; neither would answer her questions about the vaccine mandate and told her they would be sending a separation agreement. Id. ¶¶ 30–32. The separation agreement terminated Brode’s employment and offered a severance package in exchange for release of her ADA claim. See [23] at 32–37; [22] at 12, ¶ 32. Brode counter-offered, but Xeris did not accept and this suit followed. [22] at 12–13, ¶¶ 34–38. I. ADA Discrimination A disability discrimination claim under the ADA requires a plaintiff to plead that (1) she is an individual with a disability, (2) qualified to do her job with or without a reasonable accommodation, who (3) suffered an adverse employment action (4) because of her disability. See Tate v. SCR Med. Transp., 809 F.3d 343, 345 (7th Cir. 2015). In order to give the defendant fair notice of her claim, she must identify her disability. Id. at 346. The ADA defines “disability” in three ways: (1) having a physical or mental impairment that substantially limits one or major life activities of an individual; (2) a record of such an impairment; or (3) being regarded as having such an impairment. 42 U.S.C. § 12102(1). Brode alleges that Xeris misclassified her to create a record of having a disability and that Xeris regarded her as having a disability. [22] at 14–17, ¶¶ 49–70. “An individual has a record of a disability if the individual has a history of, or has been misclassified as having, a mental or physical impairment that substantially limits one or more major life activities.” 29 C.F.R. § 1630.2(k)(1). Brode alleges that by tracking which employees were vaccinated and which were not, Xeris classified its employees into those with an impairment (the unvaccinated) and those without an impairment (the vaccinated). [22] at 16–17, ¶¶ 62–70. But Brode has not alleged how being unvaccinated is a mental or physical “impairment that substantially limited one or major life activities when compared to most people in the general population,” such that being classified as “unvaccinated” is a “misclassification” creating a record of disability. See 29 C.F.R. § 1630.2(k)(2) (emphasis added). Even if Brode had alleged that being unvaccinated is an impairment under the ADA, that legal conclusion has been rejected by many courts and Brode identifies none that have accepted it. See, e.g., Linne v. Alameda Health Sys., No. 22-cv-04981- RS, 2023 WL 3168587, at *2 (N.D. Cal. April 28, 2023) (“[A] notation that Plaintiff is ‘unvaccinated’ does not indicate that Defendant recorded Plaintiff as having a disability.”); Librandi v. Alexion Pharms., Inc., No. 3:22-cv-1126(MPS), 2023 WL 3993741, at *7 (D. Conn. June 14, 2023); Sharikov v. Philips Med. Sys. MR, Inc., No. 1:22-cv-00326 (BKS/DJS), 2023 WL 2390360, at *9 (N.D.N.Y. Mar. 7, 2023), appeal docketed, No. 23-407 (2nd Cir. Mar. 21, 2023); Speaks v. Health Sys. Mgmt, Inc., No. 5:22-CV-00077-KDB-DCK, 2022 WL 3448649, at *5 (W.D.N.C. Aug. 17, 2022). Instead, Brode alleges that Xeris “is misclassifying plaintiff by gathering ‘vaccine status’ records. However, the ‘unvaccinated status’ is not the disability; rather once the defendant records the ‘vaccine status’ it alters terms and conditions of employment for the ‘unvaccinated’ implement[ing] adverse employment actions.” [22] at 17, ¶ 69.

Free access — add to your briefcase to read the full text and ask questions with AI

Brode v. Xeris Pharmaceuticals, Inc., (N.D. Ill. 2023).

Brode v. Xeris Pharmaceuticals, Inc. (Brode v. Xeris Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Casna v. City of Loves Park
574 F.3d 420 (Seventh Circuit, 2009)
Estate of Oliva v. New Jersey
589 F. Supp. 2d 539 (D. New Jersey, 2008)
Tomanovich, George v. City of Indianapolis
457 F.3d 656 (Seventh Circuit, 2006)
Richard Doermer v. Kathryn Callen
847 F.3d 522 (Seventh Circuit, 2017)
Ronald Shell v. Burlington Northern Santa Fe R
941 F.3d 331 (Seventh Circuit, 2019)
Linda Brooks v. Avancez
39 F.4th 424 (Seventh Circuit, 2022)
Suzanne Parker v. Brooks Life Science, Inc.
39 F.4th 931 (Seventh Circuit, 2022)
Erin McHale v. Denis McDonough
41 F.4th 866 (Seventh Circuit, 2022)
Skiba v. Ill. Cent. R.R. Co.
884 F.3d 708 (Seventh Circuit, 2018)
Koty v. Dupage Cnty.
900 F.3d 515 (Seventh Circuit, 2018)
Tate v. SCR Medical Transportation
809 F.3d 343 (Seventh Circuit, 2015)
Kristie Alley v. Penguin Random House
62 F.4th 358 (Seventh Circuit, 2023)